DNA And Gene Cloning Services Market Revenue to Surpass USD 11.5 BN by 2030

According to Nova one advisor, the global DNA and Gene Cloning Services market was valued at USD 4.5 billion in 2021 and it is expected to hit around USD 11.5 billion by 2030 with a CAGR of 13.7% during the forecast period 2022 to 2030

Get the Free Sample Copy of Report@ https://www.novaoneadvisor.com/report/sample/7516

Gene and DNA cloning has proven to be an invaluable tool for genetics researchers in the last few years. Advancements in genetic engineering and cloning methods have led to changes in the genome sequences of microorganisms, enabling the production of chemicals with various research and therapeutic applications. Cloning can also be utilized to create gene therapies for the treatment of diseases such as genetic disorders, cancer, and AIDS.

Gene cloning could be a feasible solution to organ scarcity. It is also required for the manufacture of antimicrobials, vitamins, and hormones. Increase in application areas of DNA and gene cloning has prompted researchers to create gene libraries, which encompass a catalogue of cloned DNA. Moreover, several players are offering DNA and gene cloning services. The global DNA and gene cloning services market is highly fragmented, with the presence of numerous start-ups, mid-sized businesses, and well-established players. These players provide a range of DNA and gene cloning services using various cloning methods. Furthermore, over 35 global events have been planned to discuss recent trends in DNA and gene cloning. The DNA and gene cloning services market is expected to grow at a steady pace in the next few years, driven by a rise in the demand for gene therapies and the introduction and adoption of novel and advanced DNA cloning technologies.

Report Scope of the DNA and Gene Cloning Services Market

Immediate Delivery Available | Buy this Premium Research Report@ https://www.novaoneadvisor.com/report/checkout/7516

Rise in Demand for Gene Therapy Driving Global Market

The term ‘gene therapy’ refers to the process of treating a disease by altering, substituting, or enhancing a missing or deficient genetic combination that causes the illness. Gene therapy is one of the most appealing research topics in the effort to combat degenerative diseases. Rise in the prevalence of cancer and other chronic diseases globally is driving the need for gene therapy. Development of gene therapies is anticipated to lead to approvals in the next few years, which in turn is projected to augment the gene therapy market during the forecast period.

The goal of gene therapy is to treat diseases by making changes to genetic information, such as deactivating broken genes or swapping out a disease-causing gene for a healthy copy. Various disorders are being treated with gene therapy effectively. Diabetes, cancer, heart disease, and AIDS can all be cured with gene therapy. A robust product portfolio, increase in investments by major players, high prevalence of target diseases, and interest in novel & innovative therapies are fueling the gene therapy market. However, high cost of product development and stringent management practices are anticipated to restrain the global market. As per global DNA and gene cloning services market forecast, increase in investment in R&D by public and private institutions is estimated to create new opportunities in the global market during the forecast period.

Introduction and Adoption of DNA Sequencing Fueling Global DNA and Gene Cloning Services Market Growth

DNA sequencing, a highly accurate and speedy technique used in several application areas, such as de novo arrangement, samples, and DNA resequencing, has caused a paradigm shift in proteomic and genomic studies. Consequently, a number of academic research organizations rapidly incorporated this technology into their research projects. In June 2020, the Whitehead Institute for Biomedical Research in Massachusetts, the U.S., installed the Illumina NovaSeq 6000 Sequencing System.

Development of DNA sequencing technology, its expanding usage in clinical diagnosis & drug discovery, and rise in R&D investment are driving the global DNA and gene cloning services market. Applications of DNA sequencing include forensics, reproductive health, personalized medicine, biomarkers, and diagnostics. The ability of next-generation sequencing (NGS) technology to identify and characterize clinically actionable genetic variants across a range of genes rapidly and affordably in a single test has recently been demonstrated. Furthermore, companies are offering services in sequencing. For instance, in December 2020, Eurofins Genomics launched SARS-CoV-2 NGS services that are both cost-effective and optimized, enabling for entire viral genome sequencing.

Rise in Prevalence of Infectious and Chronic Diseases Propelling Custom Cloning Segment

In terms of product, the custom cloning segment is expected to grow at a rapid pace during the forecast period. Custom cloning is anticipated to bring about a radical change in the biological and medical fields. Analysis of the impact of mutation on a specific gene and the production of proteins using biomedical methods are two of the primary benefits of using gene custom cloning services. Increase in penetration of synergistic services and rise in the prevalence of infectious and chronic diseases are the other factors anticipated to propel the global market during the forecast period.

Surge in Sequencing Applications Bolstering DNA Sequencing Segment

Based on application, the global DNA and gene cloning services market has been segregated into DNA sequencing, mutagenesis, genotyping and others. Rapid advances in sequencing technology and bioinformatics have made it possible to identify DNA variations. These advancements also identify variants linked to an increased risk of disease. Technological advancements, expansion of partnerships and collaborations among key players, and expansion of genome mapping initiatives globally are the other factors augmenting the DNA sequencing segment. For instance, in June 2020, the Whitehead Institute for Biomedical Research in Massachusetts, the U.S., announced that it would have Illumina’s NovaSeq 6000 Sequencing System installed in its center. In 2020, professors David Klenerman and Shankar Balasubramanian developed Next Generation DNA Sequencing technology.

Adoption of DNA and Gene Cloning Driving Pharmaceutical & Biotechnology Companies Segment

Based on end-user, the pharmaceutical & biotechnology companies segment dominated the global market in 2021. Emergence of gene cloning services is anticipated to be benefit pharmaceutical & biotechnology companies, as these offer quick, accurate, and desired constructs, which in turn allows end-users to concentrate on other crucial research steps. Hence, rapidly evolving biomedical field is anticipated to increase DNA and gene cloning services market demand in the next five years.

Regional Outlook of Global DNA and Gene Cloning Services Market

North America accounted for major share of around 35.0% of the global DNA and gene cloning services market in 2021. This is ascribed to technological developments, strategic alliances, and acquisitions in the biomedical and healthcare sectors. For instance, in December 2020, Thermo Fisher increased its clinical and commercial plasmid DNA manufacturing capabilities. The opening of a new cGMP facility in Carlsbad, California, U.S. is likely to hasten the commercialization of plasmid-based drugs and vaccines. The facility would also be capable of producing large quantities of plasmid DNA, which is a critical component of drugs used in DNA treatments. This expansion builds on the company’s ongoing commitment to provide cell and gene therapy services. Moreover, prioritization of the usage of DNA and gene cloning in the life science research industry, significant investments, funding, and collaborations are anticipated to drive industrial growth during the forecast period.

The DNA and gene cloning services market in Asia Pacific is expected to grow at a rapid pace during the forecast period due to surge in the usage of DNA and gene cloning in the life science research industry, high investments, funding, and collaborations in the region.

Analysis of Key Players in DNA and Gene Cloning Services Market

The global DNA and gene cloning services market is consolidated, with the presence of a small number of leading players. Most of the companies are investing significantly in R&D activities, primarily to introduce advanced DNA and gene cloning services. Key players are engaging in strategic alliances to increase revenue and market share. Furthermore, diversification of product portfolios and mergers & acquisitions are the key strategies adopted by prominent players to increase footprint in the market. Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, and Twist Bioscience are the prominent players operating in the global DNA and gene cloning services market.

Some of the prominent players in the DNA and Gene Cloning Services Market include:

• Aragen Life Sciences
• Bio-Techne
• Charles River Laboratories
• Curia
• Eurofins
• GenScript
• Integrated DNA Technologies
• MedGenome
• Sino Biological
• Syngene
• Twist Bioscience

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global DNA and Gene Cloning Services market

• Product Type
  • Gene Synthesis
  • Custom Cloning
  • Sub-cloning
  • Others
• Application
  • DNA Sequencing
  • Mutagenesis
  • Genotyping
  • Others
• End-user
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7516

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/